To validate the specificity of the effects of the shRNA on the glioma cells, we attempted to use a rescue strategy, in which we infected the same cells with both the mouse Sema4B cDNA and shRNA directed at the human Sema4B. The gene discussed is SEMA4B; the disease is central nervous system cancer.